Skip to main content
PZ Cormay S.A. logo

PZ Cormay S.A. — Investor Relations & Filings

Ticker · CRM ISIN · PLCMRAY00029 LEI · 2594006HZJ8OSNK56U87 WAR Manufacturing
Open in API
Filings indexed 692 across all filing types
Latest filing 2020-10-29 M&A Activity
Country PL Poland
Listing WAR CRM

About PZ Cormay S.A.

https://cormaydiagnostics.com/

PZ Cormay S.A. is a manufacturer and distributor of in-vitro diagnostic (IVD) solutions for medical laboratories and clinics. The company develops, produces, and sells a comprehensive portfolio of diagnostic reagents, laboratory analyzers, and quality control systems. Its offerings cater to key diagnostic areas, including clinical chemistry, hematology, and immunoassay. Key product lines feature the Accent series of chemistry analyzers, the Auryx immunoassay system, and the Mythic family of hematology analyzers. The company integrates its extensive experience in reagent manufacturing with advanced Swiss hematology technology to provide reliable, high-performance, and cost-effective diagnostic tools to a global network of distributors and healthcare professionals.

Recent filings

Filing Released Lang Actions
Złożenie przez PZ CORMAY S.A. deklaracji objęcia akcji nowej emisji Scope Fluidics S.A. - Content (PL)
M&A Activity Classification · 99% confidence The document details a specific corporate action: PZ CORMAY S.A. is announcing its intent to subscribe to a new share issue from Scope Fluidics S.A. for up to PLN 7,000,000.00, and securing a related loan to finance this acquisition. This involves a proposed investment, share subscription declaration, and financing arrangement. This clearly falls under activities related to capital structure changes, fundraising, or investment proposals, which aligns best with the 'Capital/Financing Update' category (CAP). It is not a general earnings release (ER), a full annual report (10-K), or a simple dividend announcement (DIV). Since it details a specific financing/investment transaction, CAP is the most precise fit.
2020-10-29 Polish
Zawarcie listu intencyjnego pomiędzy PZ CORMAY S.A. a Curiosity Diagnostics Sp. z o.o. - Content (PL)
Regulatory Filings Classification · 91% confidence The document text is a formal announcement in Polish regarding the signing of a Letter of Intent (List Intencyjny) between PZ CORMAY S.A. and Curiosity Diagnostics Sp. z o.o. concerning future distribution cooperation for a medical diagnostic system. This type of announcement details a significant business development, specifically a potential partnership or agreement that could impact the company's operations or market strategy. This falls under the category of corporate actions or strategic updates that are not standard financial reports (10-K, IR, ER) or routine administrative filings (DIV, DIRS). Since it is a specific announcement about a strategic move (entering the medical diagnostics market via a distribution agreement), it is best classified as a general regulatory announcement or a strategic/transactional update. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for significant, non-standard corporate news that doesn't fit the specific transactional codes like M&A (TAR) or Capital Changes (CAP). However, since it details a potential business transaction/collaboration, it is often categorized under general corporate news. Given the available codes, RNS serves as the best fit for a significant, non-standard regulatory disclosure that isn't explicitly covered elsewhere.
2020-10-28 Polish
AUGEBIT_FIZ_PZ_CORMAY_S.A._12.10.2020.pdf
Director's Dealing Classification · 100% confidence The document is titled "Powiadomienie o transakcji/transakcjach, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of a transaction/transactions referred to in Article 19(1) of the MAR Regulation). This regulation (Market Abuse Regulation) mandates reporting of transactions conducted by persons discharging managerial responsibilities (PDMRs) or persons closely associated with them. Section 2(a) identifies the associated person as Tadeusz Wesołowski, Vice-Chairman of the Supervisory Board. Section 4 details the transaction: 'Zbycie' (Disposal) of 500,000 shares at 2.07 PLN on 2020-10-08. This perfectly matches the definition of Director's Dealing (insider trades by executives/directors).
2020-10-13 Polish
Powiadomienie o transakcji otrzymane przez PZ CORMAY S.A. na podst. art. 19 MAR - Content (PL)
Director's Dealing Classification · 98% confidence The document text is very short (745 characters) and explicitly states that the company received a notification ('powiadomienie') regarding a transaction by a closely associated person (related to a member of the Supervisory Board) under Article 19 of the Market Abuse Regulation (MAR). Crucially, the text concludes with 'W załączeniu Spółka przekazuje treść Powiadomienia' (In the attachment, the Company transmits the content of the Notification). This structure—a brief announcement referencing an attached or enclosed document detailing insider trading—strongly suggests this is a notification of a director's or executive's personal share transaction. This aligns perfectly with the definition of Director's Dealing (DIRS). It is not a full report, nor is it a general regulatory filing (RNS) because a more specific category exists.
2020-10-13 Polish
Zgoda Rady Nadzorczej PZ CORMAY S.A. na nabycie akcji własnych Orphee SA - Content (PL)
Transaction in Own Shares Classification · 100% confidence The document text, written in Polish, discusses the Supervisory Board's approval for the Company (PZ CORMAY S.A.) to acquire 3,859,118 own shares of its subsidiary (Orphée SA) for a total price in CHF. This action is explicitly described as the final stage of capital consolidation and organizational streamlining within the CORMAY Capital Group. This directly relates to the company buying back or dealing in its own shares, which corresponds to the 'Transaction in Own Shares' definition.
2020-09-30 Polish
Zawarcie przez PZ CORMAY S.A. przedwstępnej umowy nabycia nieruchomości - Content (PL)
Regulatory Filings Classification · 98% confidence The document is a Polish regulatory filing (indicated by the structure and reference to 'raportów bieżących') updating stakeholders on a previous strategic decision regarding property (Inwestycja CP-L). Specifically, it announces the signing of a preliminary agreement to acquire a new property ('przedwstępną umowę nabycia nieruchomości') intended for the previously discussed investment. This concerns a significant business transaction and change in asset strategy, but it is not a full financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA). It is a specific update on a major business development, which fits best under the general category of Regulatory Filings (RNS) as it doesn't precisely match the other specific transaction/update codes like M&A (TAR) or Capital Change (CAP). Given its nature as a specific, non-standard update on a strategic asset move, RNS is the most appropriate fallback, although it details a significant business event.
2020-09-17 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.